Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.6836
-0.0525 (-7.13%)
At close: Apr 16, 2026, 4:00 PM EDT
0.7000
+0.0164 (2.40%)
After-hours: Apr 16, 2026, 7:58 PM EDT
Humacyte Employees
Humacyte had 184 employees as of December 31, 2025. The number of employees decreased by 36 or -16.36% compared to the previous year.
Employees
184
Change (1Y)
-36
Growth (1Y)
-16.36%
Revenue / Employee
$11,076
Profits / Employee
-$221,918
Market Cap
151.77M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 184 | -36 | -16.36% | 184 | 0 |
| Dec 31, 2024 | 220 | 35 | 18.92% | 218 | 2 |
| Dec 31, 2023 | 185 | 21 | 12.80% | 183 | 2 |
| Dec 31, 2022 | 164 | 18 | 12.33% | 164 | 0 |
| Dec 31, 2021 | 146 | - | - | 145 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| Fate Therapeutics | 161 |
| Molecular Partners AG | 134 |
| Immunic | 92 |
| Cartesian Therapeutics | 75 |
| Tenaya Therapeutics | 70 |
| Spero Therapeutics | 25 |
| Black Diamond Therapeutics | 21 |
HUMA News
- 3 days ago - Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA - Business Wire
- 7 days ago - Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 20 days ago - Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 21 days ago - Humacyte Appoints Rick McElheny as Senior Vice President of Business Development - GlobeNewsWire
- 24 days ago - Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026 - GlobeNewsWire
- 4 weeks ago - Humacyte, Inc. Announces Pricing of $20 Million Registered Direct Offering of Common Stock - GlobeNewsWire
- 4 weeks ago - Humacyte Submits Marketing Authorization Application for Symvess® in Israel for Vascular Trauma Repair - GlobeNewsWire
- 6 weeks ago - Humacyte To Participate in Upcoming Investor Conferences - GlobeNewsWire